Amgen to buy Horizon Therapeutics in $26.4B deal

Enterprise Press | Luck

Dec 12, 2022

Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion.Amgen…